Brexpiprazole

CAS: 913611-97-9

Ref. 3D-FB106463

Produktinformation

• Name: Brexpiprazole
• Synonyme: 7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one, 2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-, 7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one, 7-[4-(4-Benzo[b]thien-4-yl-1-piperazinyl)butoxy]-2(1H)-quinolinone, Opc 34712, Rexulti, Rxulti

Beschreibung

Brexpiprazole is a dopamine D2 receptor partial agonist with adjunctive antipsychotic activity for the treatment of schizophrenia. Brexpiprazole has been shown to have minimal effects on the concentration-time curve or pharmacokinetics of other antipsychotics, and it does not cause extrapyramidal symptoms. Brexpiprazole has also been shown to be effective in the treatment of major depressive disorder.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 433.57 g/mol
• Formel: C₂₅H₂₇N₃O₂S
• Reinheit: Min. 95%
• Farbe/Form: Powder
• InChl: InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)
• InChI Key: InChIKey=ZKIAIYBUSXZPLP-UHFFFAOYSA-N
• SMILES: O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1